PL338423A1 - Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 - Google Patents
Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4Info
- Publication number
- PL338423A1 PL338423A1 PL98338423A PL33842398A PL338423A1 PL 338423 A1 PL338423 A1 PL 338423A1 PL 98338423 A PL98338423 A PL 98338423A PL 33842398 A PL33842398 A PL 33842398A PL 338423 A1 PL338423 A1 PL 338423A1
- Authority
- PL
- Poland
- Prior art keywords
- leucocytes
- vla
- mediation
- compounds
- type capable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92039497A | 1997-07-31 | 1997-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL338423A1 true PL338423A1 (en) | 2000-11-06 |
Family
ID=25443662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98338423A PL338423A1 (en) | 1997-07-31 | 1998-07-30 | Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1001972A1 (en) |
JP (1) | JP2001512134A (en) |
KR (1) | KR20010022411A (en) |
CN (1) | CN1133648C (en) |
AR (1) | AR013384A1 (en) |
AU (1) | AU756696B2 (en) |
BR (1) | BR9812114A (en) |
CA (1) | CA2290747A1 (en) |
HU (1) | HUP0004259A3 (en) |
IL (1) | IL133640A0 (en) |
NO (1) | NO20000450L (en) |
NZ (1) | NZ502582A (en) |
PL (1) | PL338423A1 (en) |
TW (1) | TW534910B (en) |
WO (1) | WO1999006431A1 (en) |
ZA (1) | ZA986827B (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291511B1 (en) | 1997-05-29 | 2001-09-18 | Merck & Co., Inc. | Biarylalkanoic acids as cell adhesion inhibitors |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
US6093696A (en) * | 1997-05-30 | 2000-07-25 | Celltech Therapeutics, Limited | Tyrosine derivatives |
US6482849B1 (en) | 1997-06-23 | 2002-11-19 | Tanabe Seiyaku Co., Ltd. | Inhibitors of α4β1 mediated cell adhesion |
US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
ES2226413T3 (en) | 1998-02-26 | 2005-03-16 | Celltech Therapeutics Limited | PHENYLALANINE DERIVATIVES AS INTEGRIN ALFA-4 INHIBITORS. |
US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
GB9811159D0 (en) * | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
US6685617B1 (en) | 1998-06-23 | 2004-02-03 | Pharmacia & Upjohn Company | Inhibitors of α4β1 mediated cell adhesion |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
US6333340B1 (en) * | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
US6545003B1 (en) | 1999-01-22 | 2003-04-08 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
KR100711840B1 (en) | 1999-01-22 | 2007-05-02 | 엘란 파마슈티칼스, 인크. | Acyl derivatives which treat VLA-4 related disorders |
US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
CN1185250C (en) * | 1999-01-25 | 2005-01-19 | 依兰制药公司 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
ATE343383T1 (en) * | 1999-08-13 | 2006-11-15 | Biogen Idec Inc | CELL ADHESION INHIBITORS |
US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
KR20020067050A (en) | 1999-12-28 | 2002-08-21 | 화이자 프로덕츠 인코포레이티드 | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
WO2001079173A2 (en) | 2000-04-17 | 2001-10-25 | Celltech R & D Limited | Enamine derivatives as cell adhesion molecules |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
EP1301488A1 (en) | 2000-07-07 | 2003-04-16 | Celltech R&D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
AU2001275724A1 (en) | 2000-08-02 | 2002-02-13 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
CZ302653B6 (en) | 2000-08-18 | 2011-08-17 | Ajinomoto Co., Inc. | Phenylalanine derivatives, alpha-4-integrin antagonist, therapeutic agent or prophylactic agent and pharmaceutical composition in which the derivatives are comprised |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
US6607735B2 (en) | 2000-12-21 | 2003-08-19 | Johnson & Johnson Consumer Companies, Inc. | Method for reducing the appearance of dark circles under the eyes |
JP2004526733A (en) * | 2001-03-20 | 2004-09-02 | メルク エンド カムパニー インコーポレーテッド | Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
DE10127126A1 (en) * | 2001-06-05 | 2002-12-19 | Forschungszentrum Juelich Gmbh | New protected O-(2-substituted ethyl)-L-tyrosine derivatives, useful as intermediates for the positron emission tomography contrast agent O-(2-(18F)-fluoroethyl)-L-tyrosine |
MY140707A (en) | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
MXPA05007823A (en) * | 2003-01-24 | 2005-10-18 | Elan Pharm Inc | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents. |
EP1635822A4 (en) * | 2003-06-25 | 2009-06-24 | Elan Pharm Inc | Methods and compositions for treating rheumatoid arthritis |
ES2548853T3 (en) | 2003-12-22 | 2015-10-21 | Ajinomoto Co., Inc. | Phenylalanine derivative |
US20100150915A1 (en) | 2007-02-20 | 2010-06-17 | Stewart Edward J | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
ES2525065T3 (en) | 2008-04-11 | 2014-12-17 | Merrimack Pharmaceuticals, Inc. | Human serum albumin linkers and their conjugates |
WO2010012650A1 (en) * | 2008-07-28 | 2010-02-04 | Syddansk Universitet | Compounds for the treatment of metabolic diseases |
EP3116910A1 (en) | 2014-03-13 | 2017-01-18 | Prothena Biosciences Limited | Combination treatment for multiple sclerosis |
CA3114240C (en) | 2018-10-30 | 2023-09-05 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
SG11202103484RA (en) | 2018-10-30 | 2021-05-28 | Gilead Sciences Inc | Quinoline derivatives as alpha4beta7 integrin inhibitors |
CN112969504B (en) | 2018-10-30 | 2024-04-09 | 吉利德科学公司 | Compounds for inhibiting alpha 4 beta 7 integrin |
JP7189368B2 (en) | 2018-10-30 | 2022-12-13 | ギリアード サイエンシーズ, インコーポレイテッド | Compounds for inhibition of alpha4beta7 integrin |
CA3148613A1 (en) | 2019-08-14 | 2021-02-18 | Gilead Sciences, Inc. | Phenylalanine derived compounds and their use as inhinitors of alpha 4 beta 7 integrin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737898B (en) * | 1972-11-24 | 1974-07-31 | Hoffmann La Roche | Peptides |
CA1102316A (en) * | 1975-12-09 | 1981-06-02 | Shosuke Okamoto | N su2 xx-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
WO1992016549A1 (en) * | 1991-03-18 | 1992-10-01 | Pentapharm Ag | Parasubstituted phenylalanine derivates |
WO1995015973A1 (en) * | 1993-12-06 | 1995-06-15 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
-
1998
- 1998-07-30 CN CNB988077531A patent/CN1133648C/en not_active Expired - Fee Related
- 1998-07-30 JP JP2000505186A patent/JP2001512134A/en not_active Withdrawn
- 1998-07-30 PL PL98338423A patent/PL338423A1/en not_active IP Right Cessation
- 1998-07-30 CA CA002290747A patent/CA2290747A1/en not_active Abandoned
- 1998-07-30 IL IL13364098A patent/IL133640A0/en unknown
- 1998-07-30 BR BR9812114-6A patent/BR9812114A/en not_active Application Discontinuation
- 1998-07-30 HU HU0004259A patent/HUP0004259A3/en unknown
- 1998-07-30 AU AU86611/98A patent/AU756696B2/en not_active Ceased
- 1998-07-30 KR KR1020007000991A patent/KR20010022411A/en not_active Application Discontinuation
- 1998-07-30 EP EP98937990A patent/EP1001972A1/en not_active Withdrawn
- 1998-07-30 WO PCT/US1998/015313 patent/WO1999006431A1/en not_active Application Discontinuation
- 1998-07-30 AR ARP980103778A patent/AR013384A1/en unknown
- 1998-07-30 ZA ZA9806827A patent/ZA986827B/en unknown
- 1998-07-30 NZ NZ502582A patent/NZ502582A/en unknown
- 1998-07-31 TW TW087112638A patent/TW534910B/en not_active IP Right Cessation
-
2000
- 2000-01-28 NO NO20000450A patent/NO20000450L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU8661198A (en) | 1999-02-22 |
CN1265668A (en) | 2000-09-06 |
NO20000450D0 (en) | 2000-01-28 |
WO1999006431A1 (en) | 1999-02-11 |
KR20010022411A (en) | 2001-03-15 |
CN1133648C (en) | 2004-01-07 |
AU756696B2 (en) | 2003-01-23 |
HUP0004259A3 (en) | 2001-05-28 |
JP2001512134A (en) | 2001-08-21 |
CA2290747A1 (en) | 1999-02-11 |
TW534910B (en) | 2003-06-01 |
NZ502582A (en) | 2002-07-26 |
IL133640A0 (en) | 2001-04-30 |
EP1001972A1 (en) | 2000-05-24 |
BR9812114A (en) | 2000-07-18 |
NO20000450L (en) | 2000-03-28 |
ZA986827B (en) | 2000-05-02 |
HUP0004259A2 (en) | 2001-04-28 |
AR013384A1 (en) | 2000-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL338423A1 (en) | Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338506A1 (en) | Compounds inhibiting adhesion of leucocytes occuring through the mediation of vla-4 | |
PL338521A1 (en) | Carbamyloxylic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338510A1 (en) | Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338457A1 (en) | Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338554A1 (en) | Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338373A1 (en) | Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4 | |
IL133638A0 (en) | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 | |
AU3102797A (en) | Cell adhesion inhibiting compounds | |
AU1813599A (en) | Improvements relating to the bayer process | |
GB9712253D0 (en) | Antiviral compound | |
GB9706377D0 (en) | Novel compound | |
PL315813A1 (en) | Tetrahydropyrimidines as agents effective against arthropods | |
GB9714143D0 (en) | Improvements relating to fastening devices | |
GB9520145D0 (en) | Improvements relating to fastening devices | |
ZA937265B (en) | Laminating construction adhesive compositions with improved performance | |
GB2323142B (en) | Improvements relating to fastening systems | |
AUPP407598A0 (en) | Improvements relating to threaded fastening systems | |
GB9706178D0 (en) | Novel compound | |
GB9705451D0 (en) | Novel compound | |
GB9716927D0 (en) | Novel compound | |
GB9707872D0 (en) | Novel compound | |
GB9706335D0 (en) | Novel compound | |
GB9704158D0 (en) | Novel compound | |
GB9705614D0 (en) | Novel compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VDSO | Invalidation of derivated patent or utility model |
Ref document number: 375244 Country of ref document: PL |